Muscoril (Thiocolchicoside)

Thiocolchicoside, the active ingredient in Muscoril, is a skeletal muscle relaxant presented as an injectable solution for intramuscular use. It treats muscle spasm and related musculoskeletal pain in adult patients. GNH USA supplies Muscoril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Muscoril acts on skeletal muscle pathways to relieve spasm and pain. - Muscle spasm: reduces involuntary muscle contractions and associated discomfort. - Musculoskeletal pain: alleviates pain arising from muscles, tendons, and ligaments. - Acute low back pain: improves mobility and lessens pain during short‑term episodes.

Adverse reactions may occur with thiocolchicoside therapy.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Drowsiness: mild sedation affecting alertness. - Nausea: feeling of stomach upset. - Headache: mild to moderate cranial pain. - Injection site pain: local discomfort after intramuscular administration.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, or swelling requiring medical attention. - Hepatotoxicity: abnormal liver function tests, rarely leading to liver injury. - Seizures: rare occurrence of convulsive episodes. - Agranulocytosis: severe reduction in white blood cells, increasing infection risk. - Hypotension: significant drop in blood pressure causing dizziness or fainting.

Consider the following safety measures before using Muscoril. - Pregnancy: safety not established; avoid unless clearly needed. - Breastfeeding: unknown risk; use with caution. - Renal or hepatic impairment: dose adjustment may be required. - Elderly patients: increased sensitivity to sedative effects. - Concomitant CNS depressants: may enhance drowsiness or respiratory depression. - Store at ambient temperature: keep in original container, protect from light and moisture.

Thiocolchicoside may interact with other medicines.

Major Interactions (Avoid): - Other muscle relaxants: additive muscle weakness and respiratory depression. - CNS depressants (e.g., benzodiazepines, opioids): heightened sedation and impaired coordination. - Anticoagulants: potential increase in bleeding risk.

Moderate Interactions (Monitor Closely): - Antihistamines: may increase drowsiness. - Alcohol: can enhance sedative effects. - Lithium: possible increase in neurotoxicity.